LCM
MEDP icon

LRT Capital Management’s Medpace MEDP Stock Holding History

LRT Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,558
Closed -$748K – 94
2026
Q1 		$748K Sell
1,558
-330
-17% -$169K 0.7% 56
2025
Q4 		$1.06M Sell
1,888
-835
-31% -$474K 0.91% 45
2025
Q3 		$1.4M Buy
2,723
+768
+39% +$335K 0.93% 44
2025
Q2 		$614K Buy
1,955
+1,232
+170% +$370K 0.36% 66
2025
Q1 		$220K Buy
+723
New +$243K 0.15% 80
2024
Q4 		– Sell
-785
Closed -$262K – 104
2024
Q3 		$262K Sell
785
-531
-40% -$202K 0.24% 77
2024
Q2 		$542K Sell
1,316
-114
-8% -$45.1K 0.51% 63
2024
Q1 		$578K Sell
1,430
-534
-27% -$188K 0.52% 60
2023
Q4 		$602K Sell
1,964
-1,969
-50% -$531K 0.57% 60
2023
Q3 		$952K Sell
3,933
-3,569
-48% -$913K 0.66% 57
2023
Q2 		$1.76M Buy
+7,502
New +$1.56M 1.3% 37

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

LRT Capital Management's MEDP Position: Q2 2026 in Review

LRT Capital Management sold out of Medpace (MEDP) in Q2 2026, closing a stake of 1,558 shares — an estimated $748K sold.

LRT Capital Management first reported a position in MEDP in Q2 2023 and held it in 11 quarters. The position peaked at $1.76M in Q2 2023. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • LRT Capital Management reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • LRT Capital Management sold 1,558 Medpace shares in Q2 2026, an estimated $748K.
  • LRT Capital Management first reported a position in Medpace in Q2 2023 and held it in 11 quarters.
  • LRT Capital Management's Medpace position peaked at $1.76M in Q2 2023.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on LRT Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.